LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
To tackle HIV/AIDS in South Africa, China, through the China Global Development and South-South Cooperation Fund, has announced a two-year funding commitment of 3.49 million U.S. dollars.
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...
Zacks Investment Research on MSN
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...
New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...
Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback